Vascular Access Device Market: Growth, Size, Share, and Trends
Vascular Access Devices Market by Type (Central (PICC, Tunneled, Non-Tunnled, Port (Conventional, Power)), Peripheral (Venous (PIVC, Midline), Arterial) Intraosseous Device), Route of Insertion (IV, SC, IO), Application, End User - Global Forecast to 2030
USD 9.06 BN
MARKET SIZE, 2030
CAGR 7.1%
(2025-2030)
461
REPORT PAGES
664
MARKET TABLES
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The vascular access device market is projected to reach USD 9.06 billion by 2030 from USD 5.99 billion in 2024, at a CAGR of 7.1% during the forecast period. The market for vascular access devices is fueled by the increasing prevalence of lifestyle diseases such as cardiovascular diseases, hypertension, diabetes, and among others. Additionally, the upsurging number of chemotherapy procedures and growing use of vascular access devices in pediatric patients in boosting the market for vascular access devices.
KEY TAKEAWAYS
-
By TypeOn the basis of type, the vascular access devices market is divided into central venous access devices, peripheral vascular access devices, intraosseous vascular access devices, and accessories. Among these, the central venous access devices hold the largest market share in 2023 due to the increasing prevalence of diseases requiring vascular access diseases, such as cancer, chronic kidney diseases (CKDs), and CVDs.
-
By Route of insertionBased on route of insertion, the vascular access device market is segmented into intravenous route of insertion, subcutaneous route of insertion, and intraosseous route of insertion. Among these the intravenous route of insertion segment accounts for the largest share in the vascular access device market in 2023. As majority of the vascular aaccess devices such as Peripherally inserted central venous catheters, tunnled catheters, non-tunneled catheters, peripheral intravenous catheter, midline catheters, winged or butterfly needles are inserted via intravenous route. As the usage of these devices is increasing due to rising prevalence of lifestyle diseases, thus contributing to the market growth.
-
By ApplicationBased on application, the vascular access device market is segmented into drug administration, fluid and nutrition administration, blood transfusion, and diagnostics & testing. The drug administration segment accounts for the largest market share in vascular access device market due to increasing hospitalization for diseases which require long term drug administration such as antibiotic therapy, pain management, chemotherapy and others. For instance, as per a research article, at least 25% of cancer patients undergo chemotherapy, thus increasing demand for implantable ports, peripherally inserted central catheters and tunneled catheters.
-
By End UserOn the basis of end users, the vascular access devices market has been classified into hospitals, clinics & ambulatory care centers, and other end users (including nursing homes, laboratories, diagnostic & imaging centers, and home healthcare agencies). The hospitals segment accounted for the largest market share in 2023 due to rising funding programs to build infrastructure in rural and underserved areas and the increasing prevalence of diseases necessitating vascular access devices. Hospitals have been one of the most preferred places to treat diseases due to technological advances and the availability of the best treatment options for different illnesses.
-
By RegionBy region, the vascular access device market is divided into 5 main regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among these regions, in 2023, the North American region holds the largest market share in vascular access device market, owing to increasing prevalence of chronic diseases such ass chronic kidney diseases, cancer, cardiovascular diseases and among others.
-
Competitive LandscapeThe vascular access device market is highly competitive, dominated by key players such as Becton Dickinson & Company, Teleflex Incorporated, ICU Medical, Nipro Corporation, and Vygon. Becton Dickinson leads the market with its extensive product portfolio and strong global presence. Teleflex and ICU Medical focus on innovation and growth through product launches and strategic acquisitions, while Nipro and Vygon maintain a solid market position by offering a comprehensive range of vascular access devices across multiple regions.
The increasing prevalence of chronic diseases, such as cancer and chronic kidney diseases, drives market growth. Additionally, increased government support for the construction of healthcare infrastructure and technological advancements are expected to impact market growth. The increasing number of hospitals globally also poses an opportunistic factor for market growth.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The vascular access devices market is witnessing major trends such as the shift toward minimally invasive procedures, growing adoption of antimicrobial-coated catheters, and increasing preference for single-use and safety-engineered devices to reduce infection risks. Technological advancements in imaging-guided insertions and integration of digital monitoring systems are improving placement accuracy and patient outcomes. These developments are enhancing workflow efficiency for clinicians and ensuring better patient safety, comfort, and faster recovery, ultimately benefiting healthcare providers’ patients—the customers’ customers.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
Level
-
Growing prevalence of lifestyle diseases
-
Increasing number of chemotherapy procedures
RESTRAINTS
Impact
Level
Level
-
High cost of placement and maintenance of vascular access devices
-
Product recalls and failures
OPPORTUNITIES
Impact
Level
Level
-
Technological advancements
-
Increasing number of hospitals and expanding patient pool
CHALLENGES
Impact
Level
Level
-
Shortage of skilled healthcare professionals
-
Risks associated with vascular access devices
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Growing prevalence of lifestyle diseases
The increasing prevalence of lifestyle diseases such as diabetes and obesity, as well as diseases associated with alcohol consumption and smoking, have increased globally owing to unhealthy eating habits and a lack of physical activities. For instance, as per the CDC, 38.4 million people in the US had diabetes in 2021, with 29.7 million diagnosed cases (including 29.4 million adults). Also, on a global scale, diabetes has increased from 200 million in 1990 to 830 million in 2022 (as per the WHO report). Additionally, low- and middle-income countries experience the fastest market growth for vascular access devices due to the huge patient pool, which creates the need for advanced solutions to manage these diseases
Product recalls and failures
The market for vascular access devices is restrained by a rising number of product recalls and failures. There has been an increase in the number of product recalls due to the stringent regulatory rules imposed by various government organizations, such as FDA and CDSCO. Product malfunctioning is one of the prime restraints that can negatively impact the market due to the severe complications faced by patients. Vascular access devices directly come in contact with blood; hence, product malfunctioning can cause serious damage to the patients, including death. For this reason, several products have been recalled from various regions.
Opportunity: Technological Advancements
Advancements in the vascular access devices market have been due to technological improvements. Ultrasound is a broadly available, non-invasive technique and is thus the most broadly used vessel visualization method. As a cost-effective method, it allows the evaluation of vascular access maturity and diagnosis of complications; in recent years, image-guided vascular access has emerged as a new, efficient method offering precise results.
Challenge: Shortage of Skilled Professionals
There is a huge demand for skilled professionals, including registered nurses, physicians, doctors, and other trained healthcare professionals, to handle vascular access devices as their improper insertion may cause medical complications in patients, such as damage to blood vessels, bleeding at the site, entrance of air into the vein (air embolus), injury to the lung (pneumothorax), and bloodstream infections. This shortage of skilled professionals in major markets across the globe is expected to affect the demand and uptake of vascular access devices, as very few professionals are able to perform this on critical patients. In addition, an increasing patient load and a growing demand for complex procedures also demand an increase in skilled professionals for performing vascular access procedures, a shortage of which can lead to reduced market growth.
Vascular Access Device Market: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Portfolio spans closed PIVC systems (Nexiva) and ultrasound-guided midlines (PowerGlide Pro) for extended peripheral therapy and streamlined insertion workflows. | Closed, integrated design supports longer dwell and reduced blood exposure/needlestick risk, while midlines allow dwell up to 29 days with guidewire-assisted placement to improve insertion success. |
 |
Emergency intraosseous access (Arrow EZ-IO) and antimicrobial-impregnated short-term CVCs (Arrowg+ard Blue Plus) covering difficult access and high infection-risk patients. | IO enables access in about 10 seconds with high first-attempt success, while chlorhexidine/silver-sulfadiazine CVCs suppress microbial colonization and reduce catheter-related bloodstream infections. |
 |
Antimicrobial hemodialysis catheter caps (ClearGuard HD) standardize line access and protect catheter hubs. | Straight fluid path minimize reflux/occlusion and provide a microbial barrier, while ClearGuard HD caps achieved significant CLABSI reductions in multicenter randomized trials. |
 |
Peripheral IV catheters with ultra-sharp three-bevel needles, thin-wall flexible cannulae, and flashback chamber for rapid venous confirmation and comfortable placement. | Design targets smooth insertion, kink resistance, and patient comfort to support reliable drug, fluid, and blood administration across care settings. |
 |
Antimicrobial catheters, & Polyurethane Lifecath midlines (MST/peelable cannula kits) enabling medium-term peripheral therapy and standardized access. | Offers an effective microbial barrier with low deadspace and neutral displacement to reduce occlusion/CRBSI risk, while Lifecath supports up to roughly four weeks of therapy with insertion options that simplify placement |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The vascular access device market ecosystem includes providers, regulatory bodies, and end users. Key market players include medical device companies offering PICC lines, central venous catheters (CVCs), implantable ports, peripheral IV catheters, and other vascular access devices catering to the needs of various patients. Regulatory authorities such as the FDA, European Commission, and CDSCO ensure product safety, while technological advancements (antimicrobial coatings, ultrasound-guided insertions) enhance patient outcomes. Hospitals, specialty clinics, and home care settings are primary end users, with reimbursement policies impacting adoption. Market consolidation, partnerships, and geographic expansions shape competition, with North America leading, while the Asia Pacific sees rapid growth due to healthcare infrastructure advancements. The ecosystem thrives on R&D investments, strategic collaborations, and evolving patient-centric innovations, ensuring sustained market evolution.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Vascular Access Device Market, By Type
On the basis of type, the vascular access devices market is divided into central venous access devices, peripheral vascular access devices, intraosseous vascular access devices, and accessories. Among these, the central venous access devices hold the largest market share in 2023 due to the increasing prevalence of diseases requiring vascular access diseases, such as cancer, chronic kidney diseases (CKDs), and CVDs.
Vascular Access Device Market, By Route of insertion
Based on route of insertion, the vascular access device market is segmented into intravenous route of insertion (IV), subcutaneous route of insertion, and intraosseous route of insertion. The growth of the IV route in the vascular access device market is driven by its widespread adoption for administering essential treatments during hospitalizations. As hospitalization rates increase globally due to chronic diseases, surgical interventions, and emergency care, healthcare professionals prefer intravenous access for delivering therapies with precision and speed.
Vascular Access Device Market, By Application
Based on route of insertion, the vascular access device market is segmented into intravenous route of insertion, subcutaneous route of insertion, and intraosseous route of insertion.
Vascular Access Device Market, By End User
On the basis of end users, the vascular access devices market has been classified into hospitals, clinics & ambulatory care centers, and other end users (including nursing homes, laboratories, diagnostic & imaging centers, and home healthcare agencies). The hospitals segment accounted for the largest market share in 2023 due to rising funding programs to build infrastructure in rural and underserved areas and the increasing prevalence of diseases necessitating vascular access devices.
REGION
Asia Pacific to be fastest-growing region in endoscopy equipment market during forecast period
The Asia Pacific is the fastest-growing regional market due to the rapid expansion of vascular access device companies across key countries such as China, Japan, and India. In addition, there are numerous market participants, such as Medi-Tech Devices Pvt. Ltd (India), Nipro (Japan), Terumo Corporation (Japan), Guangdong Baihe Medical Technology Co., Ltd. (China), and Shanghai Puyi Medical Instruments Co., Ltd (China) in these countries, which contribute to market expansion and advancements in the regional market.
Vascular Access Device Market: COMPANY EVALUATION MATRIX
The vascular access device market is characterized by strong competition among leading players such as Becton Dickinson & Company, Teleflex Incorporated, ICU Medical, Nipro Corporation, and Vygon. Becton Dickinson holds a dominant position due to its extensive vascular access device portfolio, robust R&D capabilities, and widespread global presence. Teleflex and ICU Medical are focusing on innovation through advanced product launches, collaborations, and acquisitions to expand their market reach. Meanwhile, Nipro and Vygon maintain steady growth by offering comprehensive product lines across multiple regions, catering to diverse clinical requirements and strengthening their international footprint.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size, 2023 (Value) | USD 5.60 Billion |
| Market Forecast, 2030 (Value) | USD 9.06 Billion |
| Growth Rate (2024–2030) | CAGR of 7.1% from 2024 to 2030 |
| Years Considered | 2022–2030 |
| Base Year | 2023 |
| Forecast Period | 2024–2030 |
| Unit Considered | Value (USD Million/Billion); Volume (Thousand Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa |
WHAT IS IN IT FOR YOU: Vascular Access Device Market REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Company Information |
|
Insights on market share analysis by region |
| Geographic Analysis |
|
Country level demand mapping and localization strategy planning. |
RECENT DEVELOPMENTS
- September 2024 : B. Braun SE was granted 510(K) clearance by the US FDA for the Introcan Safety 2 Deep Access IV Catheter, the newest addition to the Introcan Safety 2 IV Catheter portfolio.
- June 2023 : Teleflex Incorporated (US) has been awarded two group purchasing agreements with Premier, Inc. The new agreements allow Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Teleflex’s Central Venous and Arterial Vascular Access products.
- June 2022 : Teleflex Incorporated (US) launched an Arrow Pressure Injectable Midline Catheter in Australia and New Zealand. The addition of the pressure injectable catheter further enhances the Midline portfolio to meet the expanded needs of clinicians and is designed to improve patient safety.
- January 2022 : ICU Medical, Inc. (US) acquired Smiths Medical (US) from Smiths Group PLC. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
41
2
RESEARCH METHODOLOGY
46
3
EXECUTIVE SUMMARY
60
4
PREMIUM INSIGHTS
68
5
MARKET OVERVIEW
Unlock growth potential with cutting-edge vascular access technologies amidst rising healthcare demands and challenges.
72
5.1
INTRODUCTION
5.2
MARKET DYNAMICS
5.2.1
DRIVERS
5.2.1.1
GROWING PREVALENCE OF LIFESTYLE DISEASES
5.2.1.2
INCREASING POPULARITY OF CHEMOTHERAPY PROCEDURES AMONG CANCER PATIENTS
5.2.1.3
RISING USE OF VASCULAR ACCESS DEVICES AMONG PEDIATRIC PATIENTS
5.2.2
RESTRAINTS
5.2.2.1
HIGH COST OF INSTALLATION AND MAINTENANCE OF VASCULAR ACCESS DEVICES
5.2.2.2
RISING PRODUCT RECALLS AND FAILURES
5.2.3
OPPORTUNITIES
5.2.3.1
TECHNOLOGICAL ADVANCEMENTS
5.2.3.2
INCREASING NUMBER OF HOSPITALS AND EXPANDING PATIENT POOL
5.2.4
CHALLENGES
5.2.4.1
SHORTAGE OF SKILLED HEALTHCARE PROFESSIONALS
5.2.4.2
RISKS ASSOCIATED WITH USE OF VASCULAR ACCESS DEVICES
5.3
TECHNOLOGY ANALYSIS
5.3.1
KEY TECHNOLOGIES
5.3.1.1
IMAGING AND NAVIGATION TECHNOLOGIES
5.3.1.2
CATHETER SECUREMENT AND STABILIZATION TECHNOLOGIES
5.3.2
COMPLEMENTARY TECHNOLOGIES
5.3.2.1
AI AND ML
5.3.3
ADJACENT TECHNOLOGIES
5.3.3.1
INFECTION CONTROL TECHNOLOGIES
5.4
INDUSTRY TRENDS
5.4.1
MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES
5.4.2
INNOVATIONS IN CATHETER MATERIALS AND COATINGS
5.5
VALUE CHAIN ANALYSIS
5.6
ECOSYSTEM ANALYSIS
5.6.1
ROLE IN ECOSYSTEM
5.7
SUPPLY CHAIN ANALYSIS
5.8
TRADE ANALYSIS
5.8.1
IMPORT DATA FOR HS CODE 901839
5.8.2
EXPORT DATA FOR HS CODE 901839
5.9
PORTER’S FIVE FORCES ANALYSIS
5.9.1
THREAT OF NEW ENTRANTS
5.9.2
THREAT OF SUBSTITUTES
5.9.3
BARGAINING POWER OF BUYERS
5.9.4
BARGAINING POWER OF SUPPLIERS
5.9.5
INTENSITY OF COMPETITIVE RIVALRY
5.10
KEY STAKEHOLDERS & BUYING CRITERIA
5.10.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.10.2
KEY BUYING CRITERIA
5.11
REGULATORY ANALYSIS
5.11.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2
REGULATORY FRAMEWORK
5.11.2.1
NORTH AMERICA
5.11.2.2
EUROPE
5.11.2.3
ASIA PACIFIC
5.11.2.4
LATIN AMERICA
5.11.2.5
MIDDLE EAST & AFRICA
5.12
PATENT ANALYSIS
5.12.1
INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.13
PRICING ANALYSIS
5.13.1
INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY KEY PLAYER, 2021–2023
5.13.2
INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY REGION, 2021–2023
5.14
KEY CONFERENCES & EVENTS, 2025–2026
5.15
ADJACENT MARKET ANALYSIS
5.15.1
VASCULAR CLOSURE DEVICES MARKET
5.16
UNMET NEEDS/END-USER EXPECTATIONS
5.17
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.18
INVESTMENT & FUNDING SCENARIO
5.19
IMPACT OF AI/GEN AI ON VASCULAR ACCESS DEVICES MARKET
6
VASCULAR ACCESS DEVICES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 40 Data Tables
104
6.1
INTRODUCTION
6.2
CENTRAL VENOUS ACCESS DEVICES
6.2.1
PERIPHERALLY INSERTED CENTRAL CATHETERS
6.2.1.1
BETTER DURABILITY AND INCREASED CLINICAL UTILITY FOR EXTENDED TREATMENT PLANS TO DRIVE SEGMENT
6.2.2
TUNNELED CATHETERS
6.2.2.1
LOWER RISK OF INFECTION AND SUPERIOR LONGEVITY TO SUPPORT SEGMENT GROWTH
6.2.3
NON-TUNNELED CATHETERS
6.2.3.1
NON-TUNNELED CATHETERS TO BE USED IN CRITICAL CASES WITH LIMITED PERIPHERAL ACCESS
6.2.4
IMPLANTABLE PORTS
6.2.4.1
IMPLANTABLE CONVENTIONAL PORTS
6.2.4.2
IMPLANTABLE POWER INJECTABLE PORTS
6.3
PERIPHERAL VASCULAR ACCESS DEVICES
6.3.1
PERIPHERAL VENOUS ACCESS DEVICES
6.3.1.1
PERIPHERAL INTRAVENOUS CATHETERS
6.3.1.2
MIDLINE CATHETERS
6.3.1.3
BUTTERFLY/WINGED STEEL NEEDLES
6.3.2
PERIPHERAL ARTERIAL ACCESS DEVICES
6.3.2.1
CRITICAL ROLE IN CONTINUOUS HEMODYNAMIC MONITORING AND BLOOD SAMPLING IN ACUTE CARE SETTINGS TO PROPEL SEGMENT GROWTH
6.4
ACCESSORIES
6.4.1
NEED FOR ENHANCED FUNCTIONALITY, PATIENT SAFETY, AND PROCEDURAL EFFICIENCY TO DRIVE MARKET
6.5
INTRAOSSEOUS VASCULAR ACCESS DEVICES
6.5.1
CRITICAL ROLE IN EMERGENCY SITUATIONS TO FUEL UPTAKE IN HIGH-STRESS HEALTHCARE FACILITIES
7
VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 8 Data Tables
140
7.1
INTRODUCTION
7.2
INTRAVENOUS ROUTE OF INSERTION
7.2.1
RISING NEED FOR ADMINISTERING ESSENTIAL TREATMENTS DURING ACUTE CARE TO AID MARKET GROWTH
7.3
SUBCUTANEOUS ROUTE OF INSERTION
7.3.1
REDUCED INFECTION RISK, BETTER PATIENT COMFORT, AND MINIMAL MAINTENANCE TO AUGMENT MARKET GROWTH
7.4
INTRAOSSEOUS ROUTE OF INSERTION
7.4.1
NEED FOR RAPID AND RELIABLE ACCESS IN CRITICAL EMERGENCIES TO FUEL UPTAKE
8
VASCULAR ACCESS DEVICES MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 16 Data Tables
148
8.1
INTRODUCTION
8.2
DRUG ADMINISTRATION
8.2.1
CHEMOTHERAPY
8.2.1.1
INCREASED INCIDENCE OF CANCER AND ADVANCEMENTS IN ONCOLOGY CARE TO DRIVE SEGMENT
8.2.2
OTHER DRUG ADMINISTRATION
8.3
FLUID & NUTRITION ADMINISTRATION
8.3.1
INCREASING NEED FOR INTRAVENOUS THERAPY IN CHRONIC DISEASES TO SPUR MARKET GROWTH
8.4
BLOOD TRANSFUSION
8.4.1
FREQUENT NEED FOR BLOOD TRANSFUSION FOR THALASSEMIA AND LYMPHOMA TO BOOST MARKET GROWTH
8.5
DIAGNOSTICS & TESTING
8.5.1
INCREASING RELIANCE ON ACCURATE DIAGNOSTIC IMAGING, FLUID TESTING, AND PATIENT MONITORING TO AID MARKET GROWTH
9
VASCULAR ACCESS DEVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 12 Data Tables
163
9.1
INTRODUCTION
9.2
HOSPITALS
9.2.1
PUBLIC HOSPITALS
9.2.1.1
INCREASING DEMAND FOR AFFORDABLE HEALTHCARE SERVICES IN EMERGING ECONOMIES TO DRIVE SEGMENT
9.2.2
PRIVATE HOSPITALS
9.2.2.1
RISING DEMAND FOR ADVANCED HEALTHCARE SERVICES AND HIGH-QUALITY TREATMENT OPTIONS TO DRIVE MARKET
9.3
CLINICS & AMBULATORY CARE CENTERS
9.3.1
INCREASING DEMAND FOR OUTPATIENT PROCEDURES AND COST-EFFECTIVE TREATMENTS TO BOOST SEGMENT GROWTH
9.4
OTHER END USERS
10
VASCULAR ACCESS DEVICES MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 508 Data Tables.
174
10.1
INTRODUCTION
10.2
NORTH AMERICA
10.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2
US
10.2.2.1
US TO DOMINATE NORTH AMERICAN VASCULAR ACCESS DEVICES MARKET DURING FORECAST PERIOD
10.2.3
CANADA
10.2.3.1
RISING CANCER PREVALENCE AND ADVANCED RESEARCH INITIATIVES TO PROPEL MARKET GROWTH
10.3
EUROPE
10.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2
GERMANY
10.3.2.1
RISING OBESITY RATES AND GROWING GERIATRIC POPULATION TO AUGMENT MARKET GROWTH
10.3.3
UK
10.3.3.1
INCREASED DISEASE BURDEN TO FUEL UPTAKE FOR ADVANCED VASCULAR ACCESS DEVICES FOR BETTER TREATMENT PROCEDURES
10.3.4
FRANCE
10.3.4.1
PRESENCE OF VASCULAR ACCESS DEVICE MANUFACTURERS AND TECHNOLOGICAL ADVANCEMENTS TO FUEL MARKET GROWTH
10.3.5
ITALY
10.3.5.1
STRONG GOVERNMENT HEALTHCARE POLICIES TO BOOST MARKET GROWTH
10.3.6
SPAIN
10.3.6.1
GROWING GERIATRIC POPULATION AND RISING INCIDENCE OF CHRONIC DISEASES TO FUEL MARKET GROWTH
10.3.7
REST OF EUROPE
10.4
ASIA PACIFIC
10.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2
CHINA
10.4.2.1
ADVANCED HEALTHCARE INFRASTRUCTURE AND HIGH GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
10.4.3
INDIA
10.4.3.1
RISING GOVERNMENTAL HEALTH EXPENDITURE AND INCREASING INCIDENCE OF CHRONIC DISEASES TO FUEL MARKET GROWTH
10.4.4
JAPAN
10.4.4.1
INCREASED GERIATRIC POPULATION AND HIGH PREVALENCE OF CANCER TO DRIVE MARKET
10.4.5
AUSTRALIA
10.4.5.1
INCREASED DEMAND FOR HEMODIALYSIS AND ADVANCEMENTS IN HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH
10.4.6
SOUTH KOREA
10.4.6.1
RISING BURDEN OF CHRONIC DISEASES AND INCREASING AGED POPULATION TO BOOST MARKET GROWTH
10.4.7
REST OF ASIA PACIFIC
10.5
LATIN AMERICA
10.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2
BRAZIL
10.5.2.1
GROWING CANCER BURDEN AND RISING NEED FOR LONG-TERM TREATMENT FOR CHRONIC PATIENTS TO DRIVE MARKET
10.5.3
MEXICO
10.5.3.1
INCREASING FOCUS ON DIALYSIS FOR PATIENTS WITH CHRONIC KIDNEY DISEASES TO DRIVE ADOPTION OF ADVANCED VASCULAR ACCESS DEVICES
10.5.4
REST OF LATIN AMERICA
10.6
MIDDLE EAST & AFRICA
10.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2
GCC COUNTRIES
10.6.2.1
INCREASING HEALTHCARE INVESTMENTS AND RISING PREVALENCE OF CHRONIC DISEASES TO PROPEL MARKET GROWTH
10.6.3
REST OF MIDDLE EAST & AFRICA
11
COMPETITIVE LANDSCAPE
Discover leading strategies and market positions shaping the vascular access devices competitive landscape.
357
11.1
INTRODUCTION
11.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET
11.3
REVENUE ANALYSIS, 2019–2023
11.4
MARKET SHARE ANALYSIS, 2023
11.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1
STARS
11.5.2
EMERGING LEADERS
11.5.3
PERVASIVE PLAYERS
11.5.4
PARTICIPANTS
11.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1
COMPANY FOOTPRINT
11.5.5.2
REGION FOOTPRINT
11.5.5.3
TYPE FOOTPRINT
11.5.5.4
ROUTE OF INSERTION FOOTPRINT
11.5.5.5
APPLICATION FOOTPRINT
11.5.5.6
END-USER FOOTPRINT
11.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1
PROGRESSIVE COMPANIES
11.6.2
RESPONSIVE COMPANIES
11.6.3
DYNAMIC COMPANIES
11.6.4
STARTING BLOCKS
11.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.6.5.1
DETAILED LIST OF KEY STARTUP/SME PLAYERS
11.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
11.7
COMPANY VALUATION & FINANCIAL METRICS
11.7.1
FINANCIAL METRICS
11.7.2
COMPANY VALUATION
11.8
BRAND/PRODUCT COMPARISON
11.9
COMPETITIVE SCENARIO
11.9.1
PRODUCT LAUNCHES & APPROVALS
11.9.2
DEALS
11.9.3
OTHER DEVELOPMENTS
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
378
12.1
KEY PLAYERS
12.1.1
BECTON, DICKINSON AND COMPANY
12.1.1.1
BUSINESS OVERVIEW
12.1.1.2
PRODUCTS OFFERED
12.1.1.3
RECENT DEVELOPMENTS
12.1.1.4
MNM VIEW
12.1.2
TELEFLEX INCORPORATED
12.1.3
ICU MEDICAL
12.1.4
NIPRO
12.1.5
ANGIODYNAMICS, INC.
12.1.6
VYGON
12.1.7
TERUMO CORPORATION
12.1.8
MEDTRONIC PLC
12.1.9
COOK
12.1.10
B. BRAUN SE
12.1.11
MERIT MEDICAL SYSTEMS, INC.
12.1.12
AMECATH
12.1.13
MEDICAL COMPONENTS, INC.
12.1.14
HEALTHLINE MEDICAL PRODUCTS
12.1.15
ACCESS VASCULAR, INC.
12.2
OTHER PLAYERS
12.2.1
ARGON MEDICAL DEVICES
12.2.2
PAKUMEDMEDICAL PRODUCTS GMBH
12.2.3
GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
12.2.4
PFM MEDICAL GMBH
12.2.5
MEDI-TECH DEVICES PVT. LTD.
12.2.6
KIMAL
12.2.7
POLYMEDICURE
12.2.8
DELTAMED
12.2.9
NEWTECH MEDICAL DEVICES PVT. LTD.
12.2.10
SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.
13
APPENDIX
449
13.1
DISCUSSION GUIDE
13.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3
CUSTOMIZATION OPTIONS
13.4
RELATED REPORTS
13.5
AUTHOR DETAILS
LIST OF TABLES
TABLE 1
VASCULAR ACCESS DEVICES MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
STANDARD CURRENCY CONVERSION RATES
TABLE 3
VASCULAR ACCESS DEVICES MARKET: STUDY ASSUMPTIONS
TABLE 4
VASCULAR ACCESS DEVICES MARKET: RISK ANALYSIS
TABLE 5
VASCULAR ACCESS DEVICES MARKET: ROLE IN ECOSYSTEM
TABLE 6
IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2023 (USD MILLION)
TABLE 7
EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2023 (USD MILLION)
TABLE 8
VASCULAR ACCESS DEVICES MARKET: PORTER’S FIVE FORCES
TABLE 9
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
TABLE 10
KEY BUYING CRITERIA FOR VASCULAR ACCESS DEVICES
TABLE 11
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY KEY PLAYER, 2021–2023
TABLE 17
INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY REGION, 2021–2023
TABLE 18
VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
TABLE 19
VASCULAR ACCESS DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS
TABLE 20
VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 21
VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 22
CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 23
CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 24
CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 25
CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 26
PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 27
PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 28
TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 29
TUNNELED CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 30
NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 31
NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 32
IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 33
IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 34
IMPLANTABLE PORTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 35
IMPLANTABLE PORTS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 36
IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 37
IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 38
IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 39
IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 40
PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 41
PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 42
PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 43
PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 44
PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 45
PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 46
PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 47
PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 48
PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 49
PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 50
MIDLINE CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 51
MIDLINE CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 52
BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 53
BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 54
PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 55
PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 56
ACCESSORIES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 57
ACCESSORIES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 58
INTRAOSSEOUS VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 59
INTRAOSSEOUS VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 60
VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 61
VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 62
VASCULAR ACCESS DEVICES MARKET FOR INTRAVENOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 63
VASCULAR ACCESS DEVICES MARKET FOR INTRAVENOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 64
VASCULAR ACCESS DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 65
VASCULAR ACCESS DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 66
VASCULAR ACCESS DEVICES MARKET FOR INTRAOSSEOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 67
VASCULAR ACCESS DEVICES MARKET FOR INTRAOSSEOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 68
VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 69
VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 70
VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 71
VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 72
VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 73
VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 74
VASCULAR ACCESS DEVICES MARKET FOR CHEMOTHERAPY, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 75
VASCULAR ACCESS DEVICES MARKET FOR CHEMOTHERAPY, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 76
VASCULAR ACCESS DEVICES MARKET FOR OTHER DRUG ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 77
VASCULAR ACCESS DEVICES MARKET FOR OTHER DRUG ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 78
VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 79
VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 80
VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 81
VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 82
VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 83
VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 84
VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 85
VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 86
VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 87
VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 88
PUBLIC HOSPITALS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 89
PUBLIC HOSPITALS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 90
PRIVATE HOSPITALS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 91
PRIVATE HOSPITALS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 92
VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 93
VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 94
VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 95
VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 96
VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 97
VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2024–2030 (USD MILLION)
TABLE 98
VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2030 (THOUSAND UNITS)
TABLE 99
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 100
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 101
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 102
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 103
NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 104
NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 105
NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 106
NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 107
NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 108
NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 109
NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 110
NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 111
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 112
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 113
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 114
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 115
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 116
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 117
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 118
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 119
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 120
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 121
US: KEY MACROINDICATORS
TABLE 122
US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 123
US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 124
US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 125
US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 126
US: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 127
US: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 128
US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 129
US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 130
US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 131
US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 132
US: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 133
US: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 134
US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 135
US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 136
US: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 137
US: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 138
US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 139
US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 140
US: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 141
US: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 142
CANADA: INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED, 2022–2024
TABLE 143
CANADA: KEY MACROINDICATORS
TABLE 144
CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 145
CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 146
CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 147
CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 148
CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 149
CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 150
CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 151
CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 152
CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 153
CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 154
CANADA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 155
CANADA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 156
CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 157
CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 158
CANADA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 159
CANADA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 160
CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 161
CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 162
CANADA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 163
CANADA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 164
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 165
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 166
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 167
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 168
EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 169
EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 170
EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 171
EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 172
EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 173
EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 174
EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 175
EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 176
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 177
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 178
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 179
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 180
EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 181
EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 182
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 183
EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 184
EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 185
EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 186
GERMANY: KEY MACROINDICATORS
TABLE 187
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 188
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 189
GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 190
GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 191
GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 192
GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 193
GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 194
GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 195
GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 196
GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 197
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 198
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 199
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 200
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 201
GERMANY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 202
GERMANY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 203
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 204
GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 205
GERMANY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 206
GERMANY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 207
UK: KEY MACROINDICATORS
TABLE 208
UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 209
UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 210
UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 211
UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 212
UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 213
UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 214
UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 215
UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 216
UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 217
UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 218
UK: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 219
UK: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 220
UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 221
UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 222
UK: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 223
UK: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 224
UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 225
UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 226
UK: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 227
UK: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 228
FRANCE: KEY MACROINDICATORS
TABLE 229
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 230
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 231
FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 232
FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 233
FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 234
FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 235
FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 236
FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 237
FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 238
FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 239
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 240
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 241
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 242
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 243
FRANCE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 244
FRANCE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 245
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 246
FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 247
FRANCE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 248
FRANCE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 249
ITALY: KEY MACROINDICATORS
TABLE 250
ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 251
ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 252
ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 253
ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 254
ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 255
ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 256
ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 257
ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 258
ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 259
ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 260
ITALY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 261
ITALY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 262
ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 263
ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 264
ITALY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 265
ITALY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 266
ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 267
ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 268
ITALY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 269
ITALY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 270
SPAIN: KEY MACROINDICATORS
TABLE 271
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 272
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 273
SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 274
SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 275
SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 276
SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 277
SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 278
SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 279
SPAIN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 280
SPAIN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 281
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 282
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 283
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 284
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 285
SPAIN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 286
SPAIN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 287
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 288
SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 289
SPAIN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 290
SPAIN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 291
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 292
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 293
REST OF EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 294
REST OF EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 295
REST OF EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 296
REST OF EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 297
REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 298
REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 299
REST OF EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 300
REST OF EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 301
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 302
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 303
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 304
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 305
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 306
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 307
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 308
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 309
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 310
REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 311
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 312
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 313
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 314
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 315
ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 316
ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 317
ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 318
ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 319
ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 320
ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 321
ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 322
ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 323
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 324
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 325
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 326
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 327
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 328
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 329
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 330
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 331
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 332
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 333
CHINA: KEY MACROINDICATORS
TABLE 334
CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 335
CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 336
CHINA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 337
CHINA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 338
CHINA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 339
CHINA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 340
CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 341
CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 342
CHINA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 343
CHINA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 344
CHINA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 345
CHINA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 346
CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 347
CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 348
CHINA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 349
CHINA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 350
CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 351
CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 352
CHINA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 353
CHINA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 354
INDIA: KEY MACROINDICATORS
TABLE 355
INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 356
INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 357
INDIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 358
INDIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 359
INDIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 360
INDIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 361
INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 362
INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 363
INDIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 364
INDIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 365
INDIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 366
INDIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 367
INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 368
INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 369
INDIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 370
INDIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 371
INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 372
INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 373
INDIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 374
INDIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 375
JAPAN: KEY MACROINDICATORS
TABLE 376
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 377
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 378
JAPAN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 379
JAPAN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 380
JAPAN: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 381
JAPAN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 382
JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 383
JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 384
JAPAN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 385
JAPAN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 386
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 387
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 388
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 389
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 390
JAPAN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 391
JAPAN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 392
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 393
JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 394
JAPAN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 395
JAPAN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 396
AUSTRALIA: KEY MACROINDICATORS
TABLE 397
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 398
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 399
AUSTRALIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 400
AUSTRALIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 401
AUSTRALIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 402
AUSTRALIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 403
AUSTRALIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 404
AUSTRALIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 405
AUSTRALIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 406
AUSTRALIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 407
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 408
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 409
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 410
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 411
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 412
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 413
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 414
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 415
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 416
AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 417
SOUTH KOREA: KEY MACROINDICATORS
TABLE 418
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 419
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 420
SOUTH KOREA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 421
SOUTH KOREA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 422
SOUTH KOREA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 423
SOUTH KOREA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 424
SOUTH KOREA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 425
SOUTH KOREA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 426
SOUTH KOREA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 427
SOUTH KOREA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 428
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 429
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 430
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 431
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 432
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 433
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 434
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 435
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 436
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 437
SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 438
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 439
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 440
REST OF ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 441
REST OF ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 442
REST OF ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 443
REST OF ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 444
REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 445
REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 446
REST OF ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 447
REST OF ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 448
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 449
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 450
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 451
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 452
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 453
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 454
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 455
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 456
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 457
REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 458
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 459
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
TABLE 460
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 461
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 462
LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 463
LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 464
LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 465
LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 466
LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 467
LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 468
LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 469
LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 470
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 471
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 472
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 473
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 474
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 475
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 476
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 477
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 478
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 479
LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 480
BRAZIL: KEY MACROINDICATORS
TABLE 481
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 482
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 483
BRAZIL: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 484
BRAZIL: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 485
BRAZIL: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 486
BRAZIL: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 487
BRAZIL: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 488
BRAZIL: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 489
BRAZIL: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 490
BRAZIL: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 491
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 492
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 493
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 494
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 495
BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 496
BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 497
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 498
BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 499
BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 500
BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 501
MEXICO: KEY MACROINDICATORS
TABLE 502
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 503
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 504
MEXICO: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 505
MEXICO: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 506
MEXICO: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 507
MEXICO: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 508
MEXICO: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 509
MEXICO: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 510
MEXICO: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 511
MEXICO: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 512
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 513
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 514
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 515
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 516
MEXICO: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 517
MEXICO: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 518
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 519
MEXICO: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 520
MEXICO: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 521
MEXICO: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 522
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 523
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 524
REST OF LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 525
REST OF LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 526
REST OF LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 527
REST OF LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 528
REST OF LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 529
REST OF LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 530
REST OF LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 531
REST OF LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 532
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 533
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 534
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 535
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 536
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 537
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 538
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 539
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 540
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 541
REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 542
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY REGION, 2021–2023 (USD MILLION)
TABLE 543
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY REGION, 2024–2030 (USD MILLION)
TABLE 544
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 545
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 546
MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 547
MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 548
MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 549
MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 550
MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 551
MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 552
MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 553
MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 554
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 555
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 556
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 557
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 558
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 559
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 560
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 561
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 562
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 563
MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 564
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 565
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 566
GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 567
GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 568
GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 569
GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 570
GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 571
GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 572
GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 573
GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 574
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 575
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 576
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 577
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 578
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 579
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 580
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 581
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 582
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 583
GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 584
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 585
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 586
REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 587
REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 588
REST OF MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 589
REST OF MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 590
REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 591
REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 592
REST OF MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 593
REST OF MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
TABLE 594
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
TABLE 595
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
TABLE 596
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 597
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
TABLE 598
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
TABLE 599
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
TABLE 600
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 601
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
TABLE 602
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
TABLE 603
REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
TABLE 604
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET
TABLE 605
VASCULAR ACCESS DEVICES MARKET: DEGREE OF COMPETITION
TABLE 606
VASCULAR ACCESS DEVICES MARKET: REGION FOOTPRINT
TABLE 607
VASCULAR ACCESS DEVICES MARKET: TYPE FOOTPRINT
TABLE 608
VASCULAR ACCESS DEVICES MARKET: ROUTE OF INSERTION FOOTPRINT
TABLE 609
VASCULAR ACCESS DEVICES MARKET: APPLICATION FOOTPRINT
TABLE 610
VASCULAR ACCESS DEVICES MARKET: END-USER FOOTPRINT
TABLE 611
VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 612
VASCULAR ACCESS DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 613
VASCULAR ACCESS DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 614
VASCULAR ACCESS DEVICES MARKET: DEALS, JANUARY 2021–JANUARY 2025
TABLE 615
VASCULAR ACCESS DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 616
BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 617
BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 618
BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–JANUARY 2025
TABLE 619
TELEFLEX INCORPORATED: COMPANY OVERVIEW
TABLE 620
TELEFLEX INCORPORATED: PRODUCTS OFFERED
TABLE 621
TELEFLEX INCORPORATED: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025
TABLE 622
TELEFLEX INCORPORATED: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 623
ICU MEDICAL: COMPANY OVERVIEW
TABLE 624
ICU MEDICAL: PRODUCTS OFFERED
TABLE 625
ICU MEDICAL: DEALS, JANUARY 2021–JANUARY 2025
TABLE 626
NIPRO: COMPANY OVERVIEW
TABLE 627
NIPRO: PRODUCTS OFFERED
TABLE 628
ANGIODYNAMICS, INC.: COMPANY OVERVIEW
TABLE 629
ANGIODYNAMICS, INC.: PRODUCTS OFFERED
TABLE 630
ANGIODYNAMICS, INC.: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 631
ANGIODYNAMICS, INC.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 632
VYGON: COMPANY OVERVIEW
TABLE 633
VYGON: PRODUCTS OFFERED
TABLE 634
TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 635
TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 636
MEDTRONIC PLC: COMPANY OVERVIEW
TABLE 637
MEDTRONIC PLC: PRODUCTS OFFERED
TABLE 638
COOK: COMPANY OVERVIEW
TABLE 639
COOK: PRODUCTS OFFERED
TABLE 640
B. BRAUN SE: COMPANY OVERVIEW
TABLE 641
B. BRAUN SE: PRODUCTS OFFERED
TABLE 642
B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 643
B. BRAUN SE: DEALS, JANUARY 2021–JANUARY 2025
TABLE 644
MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 645
MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
TABLE 646
MERIT MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 647
AMECATH: COMPANY OVERVIEW
TABLE 648
AMECATH: PRODUCTS OFFERED
TABLE 649
MEDICAL COMPONENTS, INC.: COMPANY OVERVIEW
TABLE 650
MEDICAL COMPONENTS, INC.: PRODUCTS OFFERED
TABLE 651
HEALTHLINE MEDICAL PRODUCTS: COMPANY OVERVIEW
TABLE 652
HEALTHLINE MEDICAL PRODUCTS: PRODUCTS OFFERED
TABLE 653
ACCESS VASCULAR, INC.: COMPANY OVERVIEW
TABLE 654
ACCESS VASCULAR, INC.: PRODUCTS OFFERED
TABLE 655
ARGON MEDICAL DEVICES: COMPANY OVERVIEW
TABLE 656
PAKUMEDMEDICAL PRODUCTS GMBH: COMPANY OVERVIEW
TABLE 657
GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 658
PFM MEDICAL GMBH: COMPANY OVERVIEW
TABLE 659
MEDI-TECH DEVICES PVT. LTD.: COMPANY OVERVIEW
TABLE 660
KIMAL: COMPANY OVERVIEW
TABLE 661
POLYMEDICURE: COMPANY OVERVIEW
TABLE 662
DELTAMED: COMPANY OVERVIEW
TABLE 663
NEWTECH MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW
TABLE 664
SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW
LIST OF FIGURES
FIGURE 1
VASCULAR ACCESS DEVICES MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
FIGURE 2
VASCULAR ACCESS DEVICES MARKET: YEARS CONSIDERED
FIGURE 3
VASCULAR ACCESS DEVICES MARKET: RESEARCH DESIGN
FIGURE 4
VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 5
VASCULAR ACCESS DEVICES MARKET: KEY PRIMARY SOURCES
FIGURE 6
VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES
FIGURE 7
VASCULAR ACCESS DEVICES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 8
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 9
MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 10
VASCULAR ACCESS DEVICES MARKET: TOP-DOWN APPROACH
FIGURE 11
MARKET SIZE ESTIMATION: DEMAND-SIDE ANALYSIS
FIGURE 12
IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VASCULAR ACCESS DEVICES MARKET
FIGURE 13
VASCULAR ACCESS DEVICES MARKET: CAGR PROJECTIONS
FIGURE 14
VASCULAR ACCESS DEVICES MARKET: DATA TRIANGULATION
FIGURE 15
CENTRAL VENOUS ACCESS DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD
FIGURE 16
TUNNELED CATHETERS TO GROW AT HIGHEST CAGR IN CENTRAL VENOUS ACCESS DEVICES MARKET FROM 2024 TO 2030
FIGURE 17
IMPLANTABLE POWER INJECTABLE PORTS TO REGISTER HIGHEST GROWTH RATE IN IMPLANTABLE PORTS MARKET DURING STUDY PERIOD
FIGURE 18
PERIPHERAL VENOUS ACCESS DEVICES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
FIGURE 19
PERIPHERAL INTRAVENOUS CATHETERS TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD
FIGURE 20
INTRAVENOUS ROUTE OF INSERTION TO HOLD LARGEST MARKET SHARE FROM 2024 TO 2030
FIGURE 21
DRUG ADMINISTRATION TO COMMAND LARGEST SHARE IN APPLICATIONS SEGMENT
FIGURE 22
CHEMOTHERAPY TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD
FIGURE 23
HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
FIGURE 24
PUBLIC HOSPITALS TO COMMAND LARGER SHARE OF HOSPITALS MARKET DURING FORECAST PERIOD
FIGURE 25
ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL MARKET FOR VASCULAR ACCESS DEVICES
FIGURE 26
RISING PREVALENCE OF CHRONIC DISEASES REQUIRING LONG-TERM TREATMENT AND CARE TO DRIVE MARKET
FIGURE 27
US AND HOSPITALS SEGMENT COMMANDED LARGEST MARKET SHARE IN 2023
FIGURE 28
ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 29
ASIA PACIFIC TO COMMAND HIGHEST GROWTH RATE FROM 2024 TO 2030
FIGURE 30
EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
FIGURE 31
VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 32
VASCULAR ACCESS DEVICES MARKET: VALUE CHAIN ANALYSIS
FIGURE 33
VASCULAR ACCESS DEVICES MARKET: ECOSYSTEM ANALYSIS
FIGURE 34
VASCULAR ACCESS DEVICES MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 35
VASCULAR ACCESS DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 36
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
FIGURE 37
KEY BUYING CRITERIA FOR TOP THREE PRODUCT TYPES
FIGURE 38
NUMBER OF PATENT PUBLICATIONS (JANUARY 2014–DECEMBER 2024)
FIGURE 39
TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VASCULAR ACCESS DEVICE PATENTS (JANUARY 2014−DECEMBER 2024)
FIGURE 40
TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR ACCESS DEVICES (JANUARY 2014− DECEMBER 2024)
FIGURE 41
VASCULAR CLOSURE DEVICES MARKET: MARKET OVERVIEW
FIGURE 42
VASCULAR ACCESS DEVICES MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
FIGURE 43
VASCULAR ACCESS DEVICES MARKET: FUNDING AND NUMBER OF DEALS, 2019–2023
FIGURE 44
VASCULAR ACCESS DEVICES MARKET: IMPACT OF AI/GEN AI
FIGURE 45
VASCULAR ACCESS DEVICES MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 46
NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
FIGURE 47
ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
FIGURE 48
REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2019–2023)
FIGURE 49
MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2023)
FIGURE 50
VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 51
VASCULAR ACCESS DEVICES MARKET: COMPANY FOOTPRINT
FIGURE 52
VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 53
EV/EBITDA OF KEY VENDORS
FIGURE 54
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 55
VASCULAR ACCESS DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 56
BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 57
TELEFLEX INCORPORATED: COMPANY SNAPSHOT
FIGURE 58
ICU MEDICAL: COMPANY SNAPSHOT
FIGURE 59
NIPRO: COMPANY SNAPSHOT
FIGURE 60
ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
FIGURE 61
TERUMO CORPORATION: COMPANY SNAPSHOT
FIGURE 62
MEDTRONIC PLC: COMPANY SNAPSHOT
FIGURE 63
B. BRAUN SE: COMPANY SNAPSHOT
FIGURE 64
MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
Methodology
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global vaccine storage equipment market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the vaccine storage equipment market. The primary sources from the demand side include pharmaceutical companies, vaccination centers, hospitals & Clinics, pharmacies, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
*C-level primaries include CEOs, CFOs, COOs, and VPs.
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global vascular access device equipment market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global vascular access device market was split into various segments and sub-segments based on:
- List of major players operating in the products market at the regional and/or country level
- Product mapping of various vaccine storage equipment manufacturers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from vascular access device (or the nearest reported business unit/product category)
- Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
- Summation of the market value of all segments/subsegments to arrive at the global vascular access device market
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Market Size Estimation (Bottom Up approach & Top down approach)
Data Triangulation
After arriving at the overall size of the global vascular access device market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Market Definition
A vascular access device (VAD) is a medical tool inserted into a vein or artery to provide direct access to the bloodstream for diagnostic or therapeutic purposes. It is commonly used for administering medications, fluids, blood products, or nutrients and for drawing blood samples. Vascular access devices are essential for patients requiring long-term intravenous treatments, such as chemotherapy or dialysis. They are classified as central or peripheral devices based on the insertion site and duration of use. These devices are usually inserted in the arm, chest, or leg, and remains in place for an extended period.
Stakeholders
- Vascular access device manufacturers and distributors
- Interventional cardiology vascular device manufacturers
- Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)
- Vendors/service providers
- Research institutes
- Niche companies manufacturing novel vascular access devices
- Research & consulting firms
Report Objectives
- To describe, analyze, and forecast the vascular access device market by product, by type, by route of insertion, by application, by end user, and region
- To describe and forecast the vascular access device market in key regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
- To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the market growth
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies2 in the vascular access device market
- To analyze competitive developments such as partnerships, collaborations, agreements & acquisitions, product launches, expansions, and R&D activities in the vascular access device market
- To analyze the impact of AI/Gen AI on the vascular access device market in terms of its capabilities, potential, use cases, and future
Key Questions Addressed by the Report
Which are the top industry players in the global vascular access devices market?
The top market players in the global vascular access device market include The prominent players in this market are Becton, Dickinson and Company (US), ICU Medical (US), Teleflex Incorporated (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Terumo Corporation (Japan), and Nipro (Japan)
What are some of the major drivers for this market?
Growth in the vascular access devices market can primarily be attributed to factors such as the growing prevalence of lifestyle diseases, the increasing number of chemotherapy procedures, and the growing use of vascular access devices in pediatric patients.
Which end users have been included in the global vascular access devices market?
This report contains the following end user segments:
- Hospitals
- Clinics & Ambulatory Care Centers
- Other End Users
Which type of vascular access device is lucrative for the vascular access devices market?
The peripheral vascular access devices segment is expected to witness the highest growth rate during the forecast period.
Which region is lucrative for the vascular access device market?
The Asia Pacific market is expected to witness the highest CAGR during the forecast period.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Vascular Access Devices Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Before You Go
Expand Beyond Vascular Access Devices Market
Explore the top 20 industries influencing your market growth
Human and AI Powered Market Intelligence
Find Untapped Markets
Growth opportunities and latent adjacency in Vascular Access Devices Market